Sign Up to like & get
recommendations!
0
Published in 2024 at "Scientific Reports"
DOI: 10.1038/s41598-024-52897-5
Abstract: Epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and hypoxia are associated with radioresistance. The goal of this study is to study the synergy of anti-HER2, trastuzumab, and anti-EGFR, cetuximab, and…
read more here.
Keywords:
anti her2;
her2 egfr;
her2;
hnscc ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Diseases of the Esophagus"
DOI: 10.1093/dote/doy089.ra10.01
Abstract: Neo-adjuvant chemotherapy (NAC) became to be a standard therapeutic strategy for advanced esophageal squamous cell carcinoma in Japan. However the multidrug combination chemotherapy with 5-FU, cisplatin (FP) and docetaxel (DFP) has been well known more…
read more here.
Keywords:
response;
expression;
her2 egfr;
her2 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-6684
Abstract: Background: Small molecular inhibitors and immunotherapy has emerged as a novel alternative treatment regime for a variety of epithelial cancers. Large number of clinical trials are in progress to gauge efficacy of tyrosine kinase inhibitors…
read more here.
Keywords:
presence;
expression;
her2 egfr;
ctcs ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.16146
Abstract: Background/Aim: Upper urinary tract urothelial carcinoma (UTUC) is a rare disease, often discovered at an advanced stage at diagnosis. Nectin-4 is expressed in a broad range of patients with UTUC and is associated with poor…
read more here.
Keywords:
egfr nectin;
her2;
her2 egfr;
urothelial carcinoma ... See more keywords